Mar­ket­ingRx roundup: Phar­ma in­dus­try rep drops in Gallup poll; Pfiz­er web­site re­veals not-yet-ap­proved drug name

Has the Covid-19 pan­dem­ic good­will ha­lo for the phar­ma in­dus­try worn off? The lat­est US Gallup an­nu­al busi­ness sec­tor poll shows it is slip­ping with a 7% drop in pos­i­tive pub­lic per­cep­tion. On­ly 18% of Amer­i­cans sur­veyed this year rat­ed their view of phar­ma as “very pos­i­tive” or “some­what pos­i­tive,” down from 25% in 2022.

That puts the in­dus­try in last place among the 25 in­dus­tries Gallup asked about. Even the fed­er­al gov­ern­ment ranked high­er at 21%, while oil and gas got 24%, and the le­gal field and ad­ver­tis­ing and pub­lic re­la­tions both cap­tured 25% of the pop­u­la­tion’s pos­i­tive per­cep­tions.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.